Global Open-Angle Glaucoma Therapeutics Market 2023-2027

Description

List of Tables

The open-angle glaucoma therapeutics market is forecasted to grow by USD 2363.93 mn during 2022-2027, accelerating at a CAGR of 6.4% during the forecast period. The report on the open-angle glaucoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by promising pipeline and recent approvals, increasing demand for combination drugs, and rising geriatric population.

Technavio's open-angle glaucoma therapeutics market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	5.5%
CAGR	6.4%
Incremental Value	$2,363.93mn

By Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Product

PGAs
Non-PGAs

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of biologics as one of the prime reasons driving the open-angle glaucoma therapeutics market growth during the next few years. Also, strategic alliances in global open-angle glaucoma therapeutics market and growing awareness about glaucoma will lead to sizable demand in the market.

The report on the open-angle glaucoma therapeutics market covers the following areas:

Open-angle glaucoma therapeutics market sizing
Open-angle glaucoma therapeutics market forecast
Open-angle glaucoma therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading open-angle glaucoma therapeutics market vendors that include AbbVie Inc., Alcon Inc., Bausch Health Companies Inc., D.Western Therapeutics Institute Inc, Hikma Pharmaceuticals Plc, Inotek Pharmaceuticals, Merck and Co. Inc., Nicox S.A., Novartis AG, Ocuphire Pharma Inc, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the open-angle glaucoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR74217

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global open-angle glaucoma therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global open-angle glaucoma therapeutics market 2017 - 2021 ($ million)
4.2 Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Channel Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Channel

6.1 Market segments
Exhibit 30: Chart on Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Channel - Market share 2022-2027 (%)
6.2 Comparison by Channel
Exhibit 32: Chart on Comparison by Channel
Exhibit 33: Data Table on Comparison by Channel
6.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Channel
Exhibit 46: Market opportunity by Channel ($ million)
Exhibit 47: Data Table on Market opportunity by Channel ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 48: Chart on Product - Market share 2022-2027 (%)
Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 PGAs - Market size and forecast 2022-2027
Exhibit 52: Chart on PGAs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on PGAs - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on PGAs - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on PGAs - Year-over-year growth 2022-2027 (%)
7.4 Non-PGAs - Market size and forecast 2022-2027
Exhibit 56: Chart on Non-PGAs - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Non-PGAs - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Non-PGAs - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Non-PGAs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Alcon Inc.
Exhibit 115: Alcon Inc. - Overview
Exhibit 116: Alcon Inc. - Business segments
Exhibit 117: Alcon Inc. - Key offerings
Exhibit 118: Alcon Inc. - Segment focus
12.5 Bausch Health Companies Inc.
Exhibit 119: Bausch Health Companies Inc. - Overview
Exhibit 120: Bausch Health Companies Inc. - Business segments
Exhibit 121: Bausch Health Companies Inc. - Key news
Exhibit 122: Bausch Health Companies Inc. - Key offerings
Exhibit 123: Bausch Health Companies Inc. - Segment focus
12.6 D.Western Therapeutics Institute Inc
Exhibit 124: D.Western Therapeutics Institute Inc - Overview
Exhibit 125: D.Western Therapeutics Institute Inc - Product / Service
Exhibit 126: D.Western Therapeutics Institute Inc - Key offerings
12.7 Hikma Pharmaceuticals Plc
Exhibit 127: Hikma Pharmaceuticals Plc - Overview
Exhibit 128: Hikma Pharmaceuticals Plc - Business segments
Exhibit 129: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 130: Hikma Pharmaceuticals Plc - Segment focus
12.8 Inotek Pharmaceuticals
Exhibit 131: Inotek Pharmaceuticals - Overview
Exhibit 132: Inotek Pharmaceuticals - Product / Service
Exhibit 133: Inotek Pharmaceuticals - Key offerings
12.9 Merck and Co. Inc.
Exhibit 134: Merck and Co. Inc. - Overview
Exhibit 135: Merck and Co. Inc. - Business segments
Exhibit 136: Merck and Co. Inc. - Key news
Exhibit 137: Merck and Co. Inc. - Key offerings
Exhibit 138: Merck and Co. Inc. - Segment focus
12.10 Nicox S.A.
Exhibit 139: Nicox S.A. - Overview
Exhibit 140: Nicox S.A. - Product / Service
Exhibit 141: Nicox S.A. - Key offerings
12.11 Novartis AG
Exhibit 142: Novartis AG - Overview
Exhibit 143: Novartis AG - Business segments
Exhibit 144: Novartis AG - Key offerings
Exhibit 145: Novartis AG - Segment focus
12.12 Ocuphire Pharma Inc
Exhibit 146: Ocuphire Pharma Inc - Overview
Exhibit 147: Ocuphire Pharma Inc - Product / Service
Exhibit 148: Ocuphire Pharma Inc - Key offerings
12.13 Otsuka Pharmaceutical Co. Ltd.
Exhibit 149: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 150: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibit 151: Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.14 Pfizer Inc.
Exhibit 152: Pfizer Inc. - Overview
Exhibit 153: Pfizer Inc. - Product / Service
Exhibit 154: Pfizer Inc. - Key news
Exhibit 155: Pfizer Inc. - Key offerings
12.15 Santen Pharmaceutical Co. Ltd.
Exhibit 156: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 157: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 158: Santen Pharmaceutical Co. Ltd. - Key offerings
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 159: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 160: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations